- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Aledade aligns with corporates to raise $100m
GV-backed Aledade has secured series D funding at a $2.2bn post-money valuation to build out the business model for its primary care network.
Jan 21, 2021Wattpad navigates to Naver in $600m acquisition
Bennett Coleman & Co, Globe Telecom and Tencent are set to exit the story sharing community operator in a cash-and-stock acquisition transaction by Naver.
Jan 21, 2021Terns tracks $100m in IPO
Lilly Asia Ventures is the largest shareholder of liver disease therapy developer Terns, which closed a $97.7m round earlier this month.
Jan 21, 2021Quali counts up $54m
The Dell and Orr Partners-backed cloud software developer has collected $54m in a round co-led by Greenfield Partners and Jerusalem Venture Partners.
Jan 21, 2021Blue Horizon blows fund up to $220m
Givaudan and Grupo Bimbo are among the limited partners in foodtech investor Blue Horizon Ventures' debut venture fund.
Jan 21, 2021Groove X tunes into $26m series B3 round
Hitachi Global Life Solutions, Sompo and NTT Docomo provided the cash for the creator of a family companion robot called Lovot, taking its total funding to $128m.
Jan 21, 2021Amazon unveils Indian accelerator partnership
The corporate launched Amazon Global Selling Propel with venture capital firms and a government-backed scheme to support emerging India-based consumer brands.
Jan 20, 2021Lovys lands series A funding
Maif Avenir has backed a $20.6m round for the digital insurance provider, which has now raised approximately $26m altogether.
Jan 20, 2021Vor Biopharma goes for $150m in IPO
Columbia University is in line for an exit as cancer drug developer Vor files for its initial public offering.
Jan 20, 2021Verve Therapeutics turns to $94m series B
Novo and GV participated in a round that lifted the Harvard, Broad Institute and Penn-linked heart disease drug developer's overall funding to more than $215m.
Jan 20, 2021Immunocore plots course to $100m IPO
The immunotherapy developer plans to go public in the US having raised $565m since being formed to develop assets of a defunct Oxford spinout.
Jan 20, 2021Rivian trucks in $2.65bn
Amazon returned for a round valuing the electric truck developer at $27.6bn as it prepares to release its first vehicles later this year.
Jan 20, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
